$243.00

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. No lead time available. Please request a quote.
Sku CI17271_100_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
4-Chloropyrrolo2,3-dpyrimidine
Brand Name
Chem Impex
Product Number
17271
CAS
3680-69-1
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
5356682
IUPAC Name
4-chloro-7H-pyrrolo2,3-dpyrimidine
InChI Key
BPTCCCTWWAUJRK-UHFFFAOYSA-N
SMILES
C1=CNC2=C1C(=NC=N2)Cl

Application

4-Chloropyrrolo2,3-dpyrimidine is widely utilized in research focused on:

Pharmaceutical Development: This compound serves as a key intermediate in the synthesis of various pharmaceuticals, particularly in the development of drugs targeting cancer and neurological disorders.

Biochemical Research: It is used in studies exploring enzyme inhibition and receptor interactions, aiding researchers in understanding complex biological pathways.

Agricultural Chemistry: The compound finds applications in the formulation of agrochemicals, contributing to the development of effective pesticides and herbicides that enhance crop protection.

Material Science: It is employed in the synthesis of novel materials, including polymers and coatings, which exhibit improved properties for various industrial applications.

Diagnostic Tools: Researchers utilize this chemical in the development of diagnostic agents, particularly in imaging techniques that require specific targeting of biological markers.

References Data Source From Pubchem

Capivasertib

Publication Name: Pharmaceutical Substances
Publication Date: 2025

Delgocitinib

Publication Name: Pharmaceutical Substances
Publication Date: 2025

A comprehensive review on synthetic strategy and MOA of marketed drugs having therapeutically potential chemical entity pyrazole

Publication Name: Journal of the Iranian Chemical Society
Publication Date: 2024-09-17
DOI: 10.1007/s13738-024-03095-7

Development of novel nitric oxide production inhibitors based on the 7H-pyrrolo[2,3-d]pyrimidine scaffold

Publication Name: Molecular Diversity
Publication Date: 2024-05-06
DOI: 10.1007/s11030-024-10866-0

PROTAC-mediated CDK degradation differentially impacts cancer cell cycles due to heterogeneity in kinase dependencies

Publication Name: British Journal of Cancer
Publication Date: 2023-08-25
DOI: 10.1038/s41416-023-02399-4